Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective...
Nashville, Tennessee (Nov. 5, 2018) - Aegis Sciences Corporation is pleased to announce definitive testing for kratom (mitragynine) via liquid chromatography-...
Employing a definitive test to detect substances whose interactions may cause adverse drug events can enhance a provider’s insights, drive clinical...
InterACT Rx™ identified at least one drug-drug interaction (DDI) between recently ingested substances in as many as 20% of patients. Nashville,...
AcuRiseID™ is a new urinalysis that monitors medication adherence in people with mental illness and substance abuse disorder Nashville, Tennessee (Sept....
Aegis Sciences director honored for career achievements Nashville, Tenn. (August 3, 2018) – Kara Allen, Aegis Sciences Corporation’s Director, Recruitment and University...
Sign up for the Aegis Newsletter